Predict your next investment

Venture Capital
washington.bizjournals.com

See what CB Insights has to offer

Investments

8

Portfolio Exits

1

About Quadrant Venture Capital

Quadrant Venture Capital Headquarter Location

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Quadrant Venture Capital

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Quadrant Venture Capital in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

Quadrant Venture Capital Investments

8 Investments

Quadrant Venture Capital has made 8 investments. Their latest investment was in Adenosine Therapeutics as part of their Series A on May 5, 2002.

CBI Logo

Quadrant Venture Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/13/2002

Series A

Adenosine Therapeutics

$1M

Yes

Other Investors

Subscribe to see more

$99M

Subscribe to see more

10

Other Investors

Subscribe to see more

$99M

Subscribe to see more

10

Other Investors

Subscribe to see more

$99M

Subscribe to see more

10

Other Investors

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/13/2002

Round

Series A

Other Investors

Other Investors

Other Investors

Other Investors

Company

Adenosine Therapeutics

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$1M

$99M

$99M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

10

10

10

10

Quadrant Venture Capital Portfolio Exits

1 Portfolio Exit

Quadrant Venture Capital has 1 portfolio exit. Their latest portfolio exit was Adenosine Therapeutics on August 15, 2008.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

8/15/2008

Acquired

$991

Date

8/15/2008

Exit

Acquired

Companies

Valuation

$991

Acquirer

Sources

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.